Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesThe Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Journal of the American Society of Nephrology, 11/25/09
Lieberthal W et al. – The include glomerular hypertrophy, intrarenal inflammation, and interstitial fibrosis. mTOR also plays an important role in mediating cyst formation and enlargement in autosomal dominant polycystic kidney disease. Inhibition of mTOR by rapamycin or one of its analogues represents a potentially novel treatment for autosomal dominant polycystic kidney disease.
Related Articles
Changing Epidemiology of End-Stage Renal Disease in Last 10 Years in Iran
Iranian Journal of Kidney Diseases, 10/13/09
Relevance Score: 69%
Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09
Relevance Score: 69%
Non-healing Skin Ulcers Secondary to Calciphylaxis with Fungemia in an End-stage Renal Disease Patient
Hong Kong Journal of Nephrology, 10/07/09
Relevance Score: 69%
Anabolic and Catabolic Mechanisms in End-Stage Renal Disease
Advances In Chronic Kidney Disease, 10/06/09
Relevance Score: 69%
Kidney injury molecule-1 in renal disease
The Journal of Pathology, 11/20/09
Relevance Score: 68%
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Potential New Therapeutic Agents for Diabetic Kidney Disease
American Journal of Kidney Diseases, 02/09/10
Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy
Journal of Obstetrics and Gynaecology Research, 02/09/10
Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril
Pharmacoepidemiology and Drug Safety, 02/09/10
Article Search
Sponsor